Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Liz Uribe"'
Publikováno v:
Siembra, Vol 11, Iss 1 (2024)
La comercialización de plaguicidas microbianos ha aumentado de manera exponencial en los últimos años. Casi el 70 % de los productos que se comercializan utilizan como principio activo conidios de hongos biocontroladores y uno de los criterios má
Externí odkaz:
https://doaj.org/article/01aca1a71b4b404c997b7a1466cd1e9b
Publikováno v:
Obstetrics & Gynecology. 141:13S-14S
Autor:
Mauricio Cruz-Barrera, Luisa Fernanda Izquierdo-García, Magda Gómez-Marroquín, Adriana Santos-Díaz, Liz Uribe-Gutiérrez, Carlos Andrés Moreno-Velandia
Biological control (BCAs) such as Trichoderma spp. minimize fungicides inputs in agriculture, and increase both the plant nutrition and the efficacy against fungal diseases. Novel bioproducts in crop management are called to guarantee sustainable ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b7dfbb2d86f655771b25fe05e9ec5ac
https://doi.org/10.21203/rs.3.rs-2264585/v1
https://doi.org/10.21203/rs.3.rs-2264585/v1
Publikováno v:
Current protocolsLiterature Cited. 2(7)
Use of biocontrol fungi (BF) such as Trichoderma spp. minimizes fungicide input and increases both plant nutrition and protection from disease. Thus, the introduction of BF by novel inoculants in crop management is an excellent strategy to promote su
Publikováno v:
Obstetrics & Gynecology. 141:13S-13S
Autor:
Merit Cudkowicz, Richard J. Barohn, Gil I. Wolfe, NeuroNEXT Nn BeatMG Study Team, Brenda Pearson, Muhammad Al-Lozi, David P. Richman, David A. Hafler, Michael Benatar, Kevin C. O’Connor, Robin Conwit, A. Gordon Smith, Eroboghene E. Ubogu, Richard Nowak, Emma Ciafaloni, Liz Uribe, Jonathan Goldstein, Mazen M. Dimachkie, Miriam Freimer, Michael E. Shy, Anthony A. Amato, Sharon P. Nations, Aditi Sharma, Jon W. Yankey, Ted M. Burns, Christopher S. Coffey, Laura Ann Sams, John T. Kissel, Dianna Quan, Volkan Granit
Publikováno v:
Neurology
Neurology, vol 98, iss 4
Neurology, vol 98, iss 4
Background and ObjectiveTo determine whether rituximab is safe and potentially beneficial, warranting further investigation in an efficacy trial for acetylcholine receptor antibody-positive generalized myasthenia gravis (AChR-Ab+ gMG).MethodsThe B-Ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a034452bec80ce3be9a64cbbab0fdb1
https://europepmc.org/articles/PMC8793103/
https://europepmc.org/articles/PMC8793103/
Autor:
Barry L. Carter, Brian M. Gryzlak, Mark W. Vander Weg, Korey A. Kennelty, Jon W. Yankey, Elizabeth A. Chrischilles, Dixie Ecklund, Gail Ardery, Alan J. Christensen, Linnea A. Polgreen, Liz Uribe, Paul A. James, Christopher S. Coffey
Publikováno v:
J Am Coll Clin Pharm
BACKGROUND: We developed a remote cardiovascular risk service (CVRS) managed by clinical pharmacists to support primary care teams. The purpose of this study was to examine whether the CVRS could improve guideline adherence in primary care clinics wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c51c7e0d52585686008e75e9bfbf85c6
https://europepmc.org/articles/PMC10234512/
https://europepmc.org/articles/PMC10234512/
Autor:
Daniel Weintraub, Parkinson's Progression Markers Initiative, Alberto J. Espay, Chelsea Caspell-Garcia, Liz Uribe, Christopher S. Coffey, Eric D. Foster
Publikováno v:
Journal of the Neurological Sciences. 402:81-85
Background A direct antidepressant effect has been reported for certain dopaminergic medications used in the treatment of Parkinson's disease (PD). Objective To examine whether dopaminergic medications may exert differential effects on mood in early
Autor:
Susan Bressman, Andrew B. Singleton, Tatiana Foroud, Tanya Simuni, Parkinson's Progression Markers Initiative Investigators, Lana M. Chahine, Liz Uribe, Arthur W. Toga, Leslie M. Shaw, Brit Mollenhauer, Andrew Siderowf, Duygu Tosun-Turgut, John Seibyl, Chelsea Caspell-Garcia, Roy N. Alcalay, Caroline M. Tanner, Karl Kieburtz, Christopher S. Coffey, Samantha J. Hutten, Doug R. Galasko, Kathleen L. Poston, Daniel Weintraub, Kelly N.H. Nudelman, John Q. Trojanowski, Michael C. Brumm, Alyssa Reimer, Kenneth Marek
Publikováno v:
Mov Disord
Movement disorders : official journal of the Movement Disorder Society, vol 35, iss 5
Movement disorders : official journal of the Movement Disorder Society, vol 35, iss 5
Background There are limited data on the phenotypic and dopamine transporter (DAT) imaging characterization of the Parkinson's disease (PD) patients with leucine rich kinase 2 (LRRK2) and glucosylceramidase beta (GBA) mutations. Objective The objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc9d46bf10ca7fdfb6d1b53cf2204ea9
https://europepmc.org/articles/PMC7231646/
https://europepmc.org/articles/PMC7231646/
Autor:
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, Chelsea Caspell-Garcia, Christopher S Coffey, Andrew Siderowf, John Q Trojanowski, Leslie M Shaw, John Seibyl, Andrew Singleton, Arthur W Toga, Doug Galasko, Tatiana Foroud, Duygu Tosun, Kathleen Poston, Daniel Weintraub, Brit Mollenhauer, Caroline M Tanner, Karl Kieburtz, Lana M Chahine, Alyssa Reimer, Samantha J Hutten, Susan Bressman, Kenneth Marek, Vanessa Arnedo, Adrienne Clark, Mark Fraiser, Catherine Kopil, Sohini Chowdhury, Todd Sherer, Nichole Daegele, Cynthia Casaceli, Ray Dorsey, Renee Wilson, Sugi Mahes, Christina Salerno, Karen Crawford, Paola Casalin, Giulia Malferrari, Mali Gani Weisz, Avi Orr-Urtreger, Thomas Montine, Chris Baglieri, Amanda Christini, David Russell, Nabila Dahodwala, Nir Giladi, Stewart Factor, Penelope Hogarth, David Standaert, Robert Hauser, Joseph Jankovic, Marie Saint-Hilaire, Irene Richard, David Shprecher, Hubert Fernandez, Katrina Brockmann, Liana Rosenthal, Paolo Barone, Alberto Espay, Dominic Rowe, Karen Marder, Anthony Santiago, Shu-Ching Hu, Stuart Isaacson, Jean-Christophe Corvol, Javiar Ruiz Martinez, Eduardo Tolosa, Yen Tai, Marios Politis, Debra Smejdir, Linda Rees, Karen Williams, Farah Kausar, Whitney Richardson, Diana Willeke, Shawnees Peacock, Barbara Sommerfeld, Alison Freed, Katrina Wakeman, Courtney Blair, Stephanie Guthrie, Leigh Harrell, Christine Hunter, Cathi-Ann Thomas, Raymond James, Grace Zimmerman, Victoria Brown, Jennifer Mule, Ella Hilt, Kori Ribb, Susan Ainscough, Misty Wethington, Madelaine Ranola, Helen Mejia Santana, Juliana Moreno, Deborah Raymond, Krista Speketer, Lisbeth Carvajal, Stephanie Carvalo, Ioana Croitoru, Alicia Garrido, Laura Marie Payne, Veena Viswanth, Lawrence Severt, Maurizio Facheris, Holly Soares, Mark A. Mintun, Jesse Cedarbaum, Peggy Taylor, Kevin Biglan, Emily Vandenbroucke, Zulfiqar Haider Sheikh, Baris Bingol, Tanya Fischer, Pablo Sardi, Remi Forrat, Alastair Reith, Jan Egebjerg, Gabrielle Ahlberg Hillert, Barbara Saba, Chris Min, Robert Umek, Joe Mather, Susan De Santi, Anke Post, Frank Boess, Kirsten Taylor, Igor Grachev, Andreja Avbersek, Pierandrea Muglia, Kaplana Merchant, Johannes Tauscher
Publikováno v:
The Lancet. Neurology, vol 19, iss 1
Lancet Neurol
Lancet Neurol
BackgroundThe Parkinson's Progression Markers Initiative (PPMI) is an ongoing observational, longitudinal cohort study of participants with Parkinson's disease, healthy controls, and carriers of the most common Parkinson's disease-related genetic mut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9491293206b421c5d364e092f50f0b5a
https://escholarship.org/uc/item/6mc189cw
https://escholarship.org/uc/item/6mc189cw